Status:
COMPLETED
Reduction of Nosocomial Vancomycin -Resistant Enterococci (VRE) Colonization and Infection by Active Surveillance and Intervention of Infection Control
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Infection
Eligibility:
All Genders
20+ years
Brief Summary
Vancomycin -resistant enterococci(VRE) has emerged as one of the most common nosocomial pathogen of health-care associated infection since 1988. Although the new antimicrobial agents such as Tigecycli...
Eligibility Criteria
Inclusion
- all patients admitted to RCC unit
Exclusion
- if the patients or family refused the exam of anal swab .
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01201031
Start Date
April 1 2010
End Date
February 1 2011
Last Update
March 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University-WanFang Hospital
Taipei, Taiwan